Study Investigates Diverse Molecular Mechanisms Driving Treatment Resistance in AML

Leggi l'articolo originale


Researchers evaluated the primary mechanisms governing drug resistance and relapse in patients treated with crenolanib, an FLT3 inhibitor.

Lascia un commento